Evaluating mobile health technologies: does the traditional randomized controlled trial serve our needs?
Robyn D GallagherLing ZhangPublished in: European journal of cardiovascular nursing (2022)
Mobile health technologies are increasingly used by cardiovascular nurses and allied health clinicians to support behaviour change and self-care in patients. Randomized controlled trials provide rigorous methodology for evaluation but progress slowly, so the technology is often outdated by completion. A helpful modification to the trial design includes identification of the behaviour intervention principles involved and concurrently track in-app usage data, allowing updates to be made. These data collected alongside user experiences enables analysis of effects on outcomes and determination of the relative influence of component parts. Cardiovascular and mental health mHealth strategies are used to exemplify these recommendations.
Keyphrases
- mental health
- randomized controlled trial
- study protocol
- end stage renal disease
- healthcare
- ejection fraction
- newly diagnosed
- chronic kidney disease
- mental illness
- clinical trial
- type diabetes
- prognostic factors
- phase iii
- palliative care
- peritoneal dialysis
- machine learning
- metabolic syndrome
- systematic review
- health information
- open label
- phase ii
- high resolution
- molecularly imprinted